| behavior |
093 |
| oxytocin |
093 |
| sexual activity |
093 |
| vasopressin |
093 |
| canities subita |
100 |
| hair bleaching |
100 |
| marie antoinette syndrome |
100 |
| melanogenesis |
100 |
| bipolar spectrum disorder |
106 |
| glp-1 |
106 |
| liraglutide |
106 |
| mood disorders |
106 |
| neuroprotection |
106 |
| obesity |
106, 147 |
| schizophrenia |
106 |
| cancer |
116 |
| immunosuppression |
116 |
| tumor |
116 |
| autism spectrum disorder |
122, 218, 247 |
| dysbiosis |
122 |
| high salt |
122 |
| long non-coding rna |
128 |
| non-coding rna |
128 |
| small non-coding rna |
128 |
| methyl-cpg-binding protein2 |
133 |
| mecp2e1 |
133 |
| mecp2e2 |
133 |
| nervous system |
133 |
| rett syndrome |
133 |
| dopamine |
139 |
| ejaculation |
139 |
| lordosis |
139 |
| rats |
139 |
| sexual behaviour |
139 |
| sexual motivation |
139 |
| depression |
147, 170, 181, 240, 274 |
| diet |
147 |
| nutrition |
147, 163 |
| hair graying |
158 |
| interferon regulatory factor 4 |
158 |
| repigmentation |
158 |
| microrna |
163 |
| polyphenol |
163 |
| brain-derived neurotrophic factor (bdnf) |
170 |
| single nucleotide polymorphism (snp) |
170 |
| val66met polymorphism. |
170 |
| copper |
181 |
| major depressive disorder |
181 |
| brain functions |
188 |
| hormonal contraceptives |
188 |
| menstrual cycle |
188 |
| mental disorders |
188 |
| mood |
188 |
| oral contraceptives |
188 |
| biosensor |
199 |
| ca+2 permeability |
199 |
| sensory physiology |
199 |
| transient receptor potential channels |
199 |
| multiple myeloma |
206 |
| myeloma |
206 |
| treatment and drugs. |
206 |
| cancer mechanism |
211 |
| cancer therapy |
211 |
| circrna |
211 |
| gene expression regulation |
211 |
| lncrna |
211 |
| mirna |
211 |
| ncrna |
211 |
| oncogene |
211 |
| tumor suppressors |
211 |
| cytokine |
218 |
| il-17 |
218 |
| il-18 |
218 |
| immune system |
218 |
| inflammation |
218 |
| alzheimer’s disease |
229 |
| hard physical work |
229 |
| leisure-time physical activity |
229 |
| occupational physical activity |
229 |
| brain-induced neurotrophic factor |
240 |
| raphe nuclei |
240 |
| serotonin |
240 |
| serotonin transporter |
240 |
| tryptophan hydroxylase. |
240 |
| cholesterol metabolism |
247 |
| cortical spreading depression |
253 |
| glutamate |
253 |
| migraine |
253 |
| dichlorodiphenyltrichloroethane |
261 |
| early puberty |
261 |
| endocrine disrupting chemicals |
261 |
| cancer vaccines |
267 |
| immunity |
267 |
| mrna vaccines |
267 |
| vaccine |
267 |
| ayahuasca |
274 |
| lysergic acid diethylamide |
274 |
| psilocybin |
274 |
| psychedelics |
274 |
